Neurometrix Inc. (NURO)

NURO Stock Earnings: NeuroMetrix Reported Results for Q1 2024 - MSN

MSN

NURO Stock Earnings: NeuroMetrix Reported Results for Q1 2024 - MSN

MSN

NURO Stock Earnings: NeuroMetrix Reported Results for Q1 2024 - MSN

MSN

Global Non-Opioid Pain Relief Device Market 2024 Research Report by Recent Developments, Company Details ... - News Channel Nebraska

News Channel Nebraska

NeuroMetrix releases pain management system - McKnight's Long-Term Care News

McKnight's Long-Term Care News

NeuroMetrix, Inc.'s (NASDAQ:NURO) CEO Might Not Expect Shareholders To Be So Generous This Year - Yahoo Finance

Yahoo Finance

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

GlobeNewswire Inc.

NeuroMetrix appoints new board director, ends ATM facility - Investing.com Canada

Investing.com Canada

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

GlobeNewswire Inc.

Echo Lake calls for firing of NeuroMetrix CEO Shai Gozani - TipRanks.com - TipRanks

TipRanks

Echo Lake calls for firing of NeuroMetrix CEO Shai Gozani - TipRanks.com - TipRanks

TipRanks

NeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022) - Yahoo Finance

Yahoo Finance

NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

NeuroMetrix Reviews Strategic Options to Enhance Growth - MD+DI

MD+DI

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call

GlobeNewswire Inc.

NeuroMetrix to review strategic options - Mass Device

Mass Device

NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024

GlobeNewswire Inc.

NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)

GlobeNewswire Inc.

NeuroMetrix Announces One-for-Eight Reverse Stock Split

GlobeNewswire Inc.

Is NeuroMetrix (NURO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap - Yahoo Finance

Yahoo Finance

NeuroMetrix is expanding its salesforce - Mass Device

Mass Device

NeuroMetrix encouraged by Phase II Quell data - Clinical Trials Arena

Clinical Trials Arena

ASCO: NeuroMetrix's wearable eases chemo-induced nerve pain - Fierce Biotech

Fierce Biotech

NeuroMetrix launches peripheral neuropathy test DPNCheck 2.0 - Medical Device Network

Medical Device Network

NeuroMetrix® Announces Launch of DPNCheck® 2.0, its Fast, Accurate, Quantitative Screening Test for Peripheral ... - GlobeNewswire

GlobeNewswire

NeuroMetrix plots launch of fibromyalgia treatment device - Fierce Biotech

Fierce Biotech

NeuroMetrix Names Jonathan Breck Harmel as National Director of Sales - citybiz

citybiz

FDA actions stimulate market for fibromyalgia devices - BioWorld Online

BioWorld Online

FDA grants Neurometrix second breakthrough device designation - BioWorld Online

BioWorld Online

Best Penny Stocks To Buy Now? 4 On Webull With Bullish User Ratings - Penny Stocks

Penny Stocks

Fibromyalgia device from NeuroMetrix gets FDA breakthrough status - Medical Device Network

Medical Device Network

Neurometrix's wearable Quell device wins FDA breakthrough designation - BioWorld Online

BioWorld Online

Woburn NeuroMetrix unveils smart watch pain relief app - Wicked Local

Wicked Local

FTC to Send Out Refunds to Some Users of NeuroMetrx's Quell - MD+DI

MD+DI

If You Had Bought NeuroMetrix (NASDAQ:NURO) Stock Five Years Ago, You'd Be Sitting On A 99% Loss, Today - Yahoo Finance

Yahoo Finance

NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018 - PR Newswire

PR Newswire

GSK to buy NeuroMetrix's wearable pain relief technology - Medical Device Network

Medical Device Network

Wearable Tech Emerging For Chronic Pain Relief - Forbes

Forbes

NeuroMetrix To Sponsor Study Assessing The Impact Of Quell Technology On Chronic Low Back Pain - Medical Design & Outsourcing

Medical Design & Outsourcing

Drug-free relief for chronic pain sufferers, thanks to a wearable device and its app - Rapid Growth

Rapid Growth

NeuroMetrix (NURO) Stock | Improving Chronic Pain Relief - Warrior Trading News

Warrior Trading News

NeuroMetrix to Showcase Quell™ Wearable Pain Relief Technology at the 2015 International Consumer Electronics ... - Business Wire

Business Wire

Zapping diabetic nerve pain with electrical stimulator you can wear day and night - Boston.com

Boston.com